{"filing":{"accession_number":"0002007919-26-000030","cik":"0002007919","ticker":"INBX","company_name":"Inhibrx Biosciences, Inc.","form":"8-K","filing_date":"2026-06-03","report_date":null,"primary_document":"inhibrx-20260603.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2007919/000200791926000030/inhibrx-20260603.htm"},"events":[{"id":7342,"run_id":6448,"accession_number":"0002007919-26-000030","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting of Stockholders held on June 3, 2026. The filing reports voting outcomes for two proposals: (1) election of Class II directors Douglas G. Forsyth and Kimberly Manhard, and (2) ratification of BDO USA, P.C. as the independent auditor. The detailed vote tallies (votes for, against, withheld, abstained, and broker non-votes) are the hallmark of Item 5.07 disclosures and are material to investors assessing board composition and audit oversight.","company_name":"Inhibrx Biosciences, Inc.","ticker":"INBX","filing_date":"2026-06-03","form":"8-K","submitted_at":null,"items":[{"id":4192,"accession_number":"0002007919-26-000030","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting of Stockholders held on June 3, 2026. The filing reports voting outcomes for two proposals: (1) election of Class II directors Douglas G. Forsyth and Kimberly Manhard, and (2) ratification of BDO USA, P.C. as the independent auditor. The detailed vote tallies (votes for, against, withheld, abstained, and broker non-votes) are the hallmark of Item 5.07 disclosures and are material to investors assessing board composition and audit oversight.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-04T02:53:47.342094+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":4192,"accession_number":"0002007919-26-000030","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting of Stockholders held on June 3, 2026. The filing reports voting outcomes for two proposals: (1) election of Class II directors Douglas G. Forsyth and Kimberly Manhard, and (2) ratification of BDO USA, P.C. as the independent auditor. The detailed vote tallies (votes for, against, withheld, abstained, and broker non-votes) are the hallmark of Item 5.07 disclosures and are material to investors assessing board composition and audit oversight.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-04T02:53:47.342094+00:00","company_name":"Inhibrx Biosciences, Inc.","ticker":"INBX","filing_date":"2026-06-03"}]}